Research

The Shirley E. Greenberg Women’s Health Centre seeks to answer important clinical and policy questions that directly impact women’s reproductive health care through innovative research programs. The Centre’s research unit has yielded many valuable advancements in women’s health.

Research Chairs

Clinical trials

AbbVie M14-702 Trial

A Phase 3 study to evaluate the safety and efficacy of Elagolix in combination with Estradiol/Norethindrone Acetate in subjects with moderate to severe endometriosis-associated pain.

Allergan Capture Registry

Using a patient registry in a multicenter prospective non-interventional study to assess the management of Canadian womenwith uterine fibroids.

Bayer Asteroid Trial

A randomized, parallel-group, multicenter study to assess the efficacy and safety of Vilaprisan in subjects with uterine fibroids.

Bayer Villendo Trial

A randomized, double-blind, parallel-group, multicenter Phase 2b study to assess the efficacy and safety of two different doses of Vilaprisan (BAY 1002670) versus placebo in women with symptomatic endometriosis.

EPHECT Registry

Using a patient registry to study the relation between clinical symptoms and the presentation of endometriosis.

This webpage uses gendered language but is meant to be inclusive of all individuals, including gender diverse individuals who may not identify as women/female. The staff at SEGWHC is committed to respecting the rights of all people for whom this webpage may apply, including but not limited to transgender, gender non-binary, and intersex people.

Last updated on: February 25th, 2020

toh